Inflammatory pathway mediator

Inflammatory pathway mediator" is not the name of a specific molecule, protein, or receptor. Instead, it refers to a broad group of substances—including cytokines, prostaglandins, histamine, leukotrienes, and complement proteins—that are released by immune system cells to regulate and orchestrate the inflammatory response[1][2][3]. These mediators can be cell-derived or plasma-derived and play diverse roles in increasing blood flow to affected areas, recruiting immune cells to sites of injury or infection, inducing fever and pain responses, and promoting tissue repair[1]. Because 'inflammatory pathway mediator' does not refer to one defined molecular entity but rather an entire functional category encompassing many different molecules with varied structures and mechanisms of action[1][2], it cannot be considered a canonical therapeutic target. For structured data purposes—such as drug interaction mapping or biomarker identification—a more specific target name (e.g., "Tumor necrosis factor alpha," "Interleukin 6," "Prostaglandin E2 receptor") would be required.

Other names

Inflammatory mediatorInflammatory mediators